Literature DB >> 15897943

Neuroimaging: anything to do with neurotherapeutics?

Jose C Masdeu, Rohit Bakshi.   

Abstract

Mesh：

Year:  2005        PMID： 15897943      PMCID： PMC1064984          DOI： 10.1602/neurorx.2.2.163

Source DB:  PubMed          Journal:  NeuroRx        ISSN： 1545-5343


× No keyword cloud information.
  17 in total

1.  MRI as a biomarker of disease progression in a therapeutic trial of milameline for AD.

Authors:  C R Jack; M Slomkowski; S Gracon; T M Hoover; J P Felmlee; K Stewart; Y Xu; M Shiung; P C O'Brien; R Cha; D Knopman; R C Petersen
Journal:  Neurology       Date:  2003-01-28       Impact factor: 9.910

Review 2.  Looking backward to move forward: early detection of neurodegenerative disorders.

Authors:  Steven T DeKosky; Kenneth Marek
Journal:  Science       Date:  2003-10-31       Impact factor: 47.728

Review 3.  Alzheimer's disease.

Authors:  Jeffrey L Cummings
Journal:  N Engl J Med       Date:  2004-07-01       Impact factor: 91.245

Review 4.  Positron emission tomography and single-photon emission computed tomography in central nervous system drug development.

Authors:  David J Brooks
Journal:  NeuroRx       Date:  2005-04

5.  Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease.

Authors:  G W Small; L M Ercoli; D H Silverman; S C Huang; S Komo; S Y Bookheimer; H Lavretsky; K Miller; P Siddarth; N L Rasgon; J C Mazziotta; S Saxena; H M Wu; M S Mega; J L Cummings; A M Saunders; M A Pericak-Vance; A D Roses; J R Barrio; M E Phelps
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

6.  In vivo visualization of Alzheimer's amyloid plaques by magnetic resonance imaging in transgenic mice without a contrast agent.

Authors:  Clifford R Jack; Michael Garwood; Thomas M Wengenack; Bret Borowski; Geoffrey L Curran; Joseph Lin; Gregor Adriany; Olli H J Gröhn; Roger Grimm; Joseph F Poduslo
Journal:  Magn Reson Med       Date:  2004-12       Impact factor: 4.668

Review 7.  Imaging in neurooncology.

Authors:  Andreas H Jacobs; Lutz W Kracht; Axel Gossmann; Maria A Rüger; Anne V Thomas; Alexander Thiel; Karl Herholz
Journal:  NeuroRx       Date:  2005-04

8.  Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL-PET study.

Authors:  Alan L Whone; Ray L Watts; A Jon Stoessl; Margaret Davis; Sven Reske; Claude Nahmias; Anthony E Lang; Olivier Rascol; Maria J Ribeiro; Philippe Remy; Werner H Poewe; Robert A Hauser; David J Brooks
Journal:  Ann Neurol       Date:  2003-07       Impact factor: 10.422

Review 9.  Toward Alzheimer therapies based on genetic knowledge.

Authors:  John Hardy
Journal:  Annu Rev Med       Date:  2004       Impact factor: 13.739

10.  Selective COX-2 inhibition prevents progressive dopamine neuron degeneration in a rat model of Parkinson's disease.

Authors:  Rosario Sánchez-Pernaute; Andrew Ferree; Oliver Cooper; Meixiang Yu; Anna-Liisa Brownell; Ole Isacson
Journal:  J Neuroinflammation       Date:  2004-05-17       Impact factor: 8.322
View more
  2 in total

Review 1.  MR imaging features of high-grade gliomas in murine models: how they compare with human disease, reflect tumor biology, and play a role in preclinical trials.

Authors:  A R Borges; P Lopez-Larrubia; J B Marques; S G Cerdan
Journal:  AJNR Am J Neuroradiol       Date:  2011-12-22       Impact factor: 3.825

2.  The future of neurology.

Authors:  José Biller; Michael J Schneck
Journal:  Front Neurol       Date:  2011-02-04       Impact factor: 4.003
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.